BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21838460)

  • 1. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis.
    Meier-Ewert HK; Sanchorawala V; Berk J; Finn KT; Skinner M; Seldin DC; Ruberg FL
    Amyloid; 2011 Jun; 18 Suppl 1():130-1. PubMed ID: 21838460
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
    Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
    Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.
    Seldin DC; Andrea N; Berenbaum I; Berk JL; Connors L; Dember LM; Doros G; Fennessey S; Finn K; Girnius S; Lerner A; Libbey C; Meier-Ewert HK; O'Connell R; O'Hara C; Quillen K; Ruberg FL; Sam F; Segal A; Shelton A; Skinner M; Sloan JM; Wiesman JF; Sanchorawala V
    Amyloid; 2011 Jun; 18 Suppl 1(Suppl 1):127-9. PubMed ID: 21838459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
    Comenzo RL; Steingart RM; Cohen AD
    N Engl J Med; 2008 Jan; 358(1):92; author reply 92-3. PubMed ID: 18175384
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
    Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
    Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.
    Palladini G; Russo P; Nuvolone M; Lavatelli F; Perfetti V; Obici L; Merlini G
    Blood; 2007 Jul; 110(2):787-8. PubMed ID: 17606766
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation for amyloidosis.
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
    Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of immunoglobulin light chain (primary or AL) amyloidosis.
    Gertz MA; Buadi FK; Hayman SR
    Oncology (Williston Park); 2011 Jun; 25(7):620-6. PubMed ID: 21888261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
    Decker I; Goodman SA; Phillips SE; Lenihan DJ; Cornell RF
    Br J Haematol; 2017 May; 177(3):481-483. PubMed ID: 28295184
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
    Jaccard A; Moreau P; Leblond V; Leleu X; Benboubker L; Hermine O; Recher C; Asli B; Lioure B; Royer B; Jardin F; Bridoux F; Grosbois B; Jaubert J; Piette JC; Ronco P; Quet F; Cogne M; Fermand JP;
    N Engl J Med; 2007 Sep; 357(11):1083-93. PubMed ID: 17855669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
    Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
    Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of immunoglobulin light chain amyloidosis.
    Gertz MA; Zeldenrust SR
    Curr Hematol Malig Rep; 2009 Apr; 4(2):91-8. PubMed ID: 20425420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation in light chain amyloidosis: coming out of the cupboard.
    Bridoux F; Ronco P; Gillmore J; Fermand JP
    Nephrol Dial Transplant; 2011 Jun; 26(6):1766-8. PubMed ID: 21486870
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
    Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
    Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
    Hayes-Lattin BM; Curtin PT; Fleming WH; Leis JF; Stepan DE; Schubach S; Maziarz RT
    Bone Marrow Transplant; 2002 Sep; 30(5):279-85. PubMed ID: 12209349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
    Herrmann SM; Gertz MA; Stegall MD; Dispenzieri A; Cosio FC; Kumar S; Lacy MQ; Dean PG; Prieto M; Zeldenrust SR; Buadi FK; Russell SJ; Nyberg SL; Hayman SR; Dingli D; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2011 Jun; 26(6):2032-6. PubMed ID: 21543655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation for IgM amyloidosis and IgM myeloma.
    Gertz MA; Hayman SR; Buadi FK
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):77-9. PubMed ID: 19362980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
    Sanchorawala V; Wright DG; Quillen K; Finn KT; Dember LM; Berk JL; Doros G; Fisher C; Skinner M; Seldin DC
    Bone Marrow Transplant; 2007 Sep; 40(6):557-62. PubMed ID: 17589534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.